
TSE:BNS
This summary was created by AI, based on 30 opinions in the last 12 months.
The Bank of Nova Scotia (BNS) has elicited mixed reviews from experts. Some highlight its strong positioning for future growth due to investments in GenAI and a favorable regulatory environment that allows for increased lending capacity. However, others express concerns about BNS's performance relative to its Canadian peers, noting it as the weakest among them despite a decent dividend yield of around 4.5% and recent strategic moves to invest in the U.S. market through KEY. While some analysts see potential for long-term gains, particularly with the new CEO at the helm, others urge caution citing stagnant loan growth and rising provisions for credit losses (PCLs). The overall sentiment reflects a blend of optimism for its turnaround and skepticism about its ability to catch up to its competitors amidst ongoing economic challenges.
He likes it beacuse it's only 50% Canadian. His rule is to buy the weakest-performing Canadian bank in a given year, that bank becomes the best bank 12-14 years in a row. That's BNS now, which has had a pullback due to a large purchase and an equity issue. So, BNS trails the other banks. But he sees a reversion to the mean--and his rule. Their international business is going great and BNS has avoided the worst turbulence in Latin America. Its earnings are growing double-digits in the past few quarters.. (Analysts' price target: $86.40)
Why has TD outperformed BNS in the past year? Hes warming up to BNS now. It has a good valuation, though he likes TD very much. BNS suffers from NAFTA talks and Latin American exposure, where some countries suffer
hyperinflation and struggling economies. That said, you can sell another Canadian bank and buy BNS now.
It's focused in Latin America, a good growth profile for BNS, but there's risk and volatility in these countries. The banking systems in those countries are less mature and have weaker governance. BNS has done a good job trimming costs and made several big asset purchases like MD Management. It's a good company.
It's broken an up trendline. That doesn't mean it's bearish. It's been sideways, range-trading. He doesn't see a big rally coming up. BNS is exposed to Latin America and Argentina has some issues with debt and deficits--their peso is
plunging. This has partially triggered the recent sell-off. He would lighten his holdings.
This company has reported great earnings but it is down. He doesn’t know why. There is a significant concern about consumer debt levels and mortgage levels and this will depress the price of the Canadian bank stocks. He expects the dividend to grow a bit but doesn’t expect much capital appreciation. He expects that TD and Royal Bank should trade better than Scotia because they have expanded in the US more than Scotia.
This is the only Canadian bank they own. This is the most international bank in Canada, with more assets being owned outside of the country. These assets are not in the US. It has been hitting recent lows. When it sold its CI holdings, getting out of mutual funds, they have been buying a large asset manager and a private client business focusing on physician investors. The problem is the market feels they may have overpaid for these investments. Yield 4.4%. (Analysts’ price target is $86.40)